ITM Isotope Technologies Munich SE

📍 Garching near Munich, Germany🗓 Founded 2004👥 586 employees💰 Last funded Nov 2016
PASSION FOR PRECISION. ITM, a leading radiopharmaceutical biotech company, is dedicated to providing a new generation of radiopharmaceutical therapeutics and diagnostics for hard-to-treat tumors. We aim to meet the needs of cancer patients, clinicians and our partners through excellence in development, production and global supply. With improved patient benefit as the driving principle for all we do, ITM advances a broad precision oncology pipeline, including multiple Phase 3 studies, combining the company’s high-quality radioisotopes with a range of targeting molecules. By leveraging our two decades of pioneering radiopharma expertise, central industry position and established global network, ITM strives to provide patients with more effective targeted treatment to improve clinical outcome and quality of life. For more information please visit: www.itm-radiopharma.com. Please see our Community Guidelines: https://isotope-technologies-munich.com/service/community-guidelines
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2004
Founded
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in ITM Isotope Technologies Munich SE?
ITM Isotope Technologies Munich SE has 1 investors on record on gritt.io.
When did ITM Isotope Technologies Munich SE last raise funding?
The most recent investment in ITM Isotope Technologies Munich SE recorded on gritt.io was in November 2016.
When was ITM Isotope Technologies Munich SE founded?
ITM Isotope Technologies Munich SE was founded in 2004.
What industry is ITM Isotope Technologies Munich SE in?
ITM Isotope Technologies Munich SE operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is ITM Isotope Technologies Munich SE based?
ITM Isotope Technologies Munich SE is headquartered in Garching near Munich, Germany.